Nebula Genomics, EMD Serono to Incentivize Blockchain Genomic Data Generation and Sharing
- Nebula Genomics and EMD Serono collaborate to create a DLT solution
- The goal is to incentivize genomic data generation and sharing, among other things
The blockchain company Nebula genomics and EMD Serono, will be working together in order to incentivize genomic data generation and sharing. The information was released by these companies in a press release.
Nebula Genomics and EMD Serono Announce Collaboration
These two companies are working together not only to incentivize genomic data generation and sharing but also to lower the costs of genome-sequencing. They were also preserving privacy and individuals’ control over the data they have.
Nebula is a blockchain platform that works with genome-sequencing data and it was co-founded by the geneticist Professor George Church. Other recognized colleagues that co-founded the firm were Dennis Grishin anKamal Obbad.
Nebula explained that the new agreement with EMD Serono is the first attempt to realize a model of sponsored genome sequencing. It is also possible for lung cancer patients to register for free high-coverage germline and tumour whole-genome sequencing. This can help them make better choices regarding their treatments.
Although it is very positive to have a large analysis dataset, there are some challenges that the blockchain and crypto industries must solve in order to realize their potential.
The pharmaceutical firm Boehringer Ingelheim has also partnered with the blockchain healthcare platform called Solve.Care in order to build a blockchain network for sharing data with patients affected with diabetes.
There are several companies and firms that are working with blockchain technology to innovate through systems and products in the healthcare industry around the world.